Related Experiment Video
Updated: Jul 18, 2026
06:16
White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
Published on: September 9, 2025
[Subfertility in overweight women].
W K H Kuchenbecker1, A E Ruifrok, J H T Bolster
1Isala klinieken, afd. Obstetrie en Gynaecologie, Postbus 10.500, 8000 GM Zwolle. w.k.h.kuchenbecker@isala.nl
Nederlands Tijdschrift Voor Geneeskunde
|December 2, 2006
Summary
Overweight women face reduced fertility and increased risks during pregnancy. Modest weight loss can significantly improve conception chances and pregnancy outcomes.
Area of Science:
- Reproductive Endocrinology
- Obesity Medicine
- Public Health
Context:
- Rising global prevalence of overweight individuals, particularly noted in The Netherlands.
- Overweight status in women of reproductive age is linked to significant reproductive health challenges.
Purpose:
- To investigate the impact of overweight and obesity on female fertility and pregnancy outcomes.
- To evaluate the efficacy of weight loss interventions in improving reproductive health for overweight women.
Summary:
- Overweight women experience lower spontaneous and assisted conception rates compared to normal-weight women.
- Increased risk of miscarriage and pregnancy complications are associated with overweight and obesity.
- A 5-15% weight loss through diet, exercise, and behavioral changes enhances fertility and pregnancy outcomes in subfertile overweight women.
Impact:
- Highlights the critical link between body weight and reproductive success in women.
- Provides evidence-based recommendations for lifestyle modifications to improve fertility and pregnancy health.
- Informs public health strategies for managing overweight and obesity to address reproductive health concerns.
Related Concept Videos
01:28Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...
01:23Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...